HDL as a drug and nucleic acid delivery vehicle
This review is intended to evaluate the research findings and potential clinical applications of drug transport systems, developed based on the concepts of the structure/function and physiological role(s) of high density lipoprotein=type nanoparticles. These macromolecules provide targeted transport...
Saved in:
Main Authors: | Andras G Lacko (Author), Nirupama Avinash Sabnis (Author), Bhavani eNagarajan (Author), Walter James McConathy (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
by: Andras G. Lacko, et al.
Published: (2013) -
Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
by: Sangram Raut, et al.
Published: (2018) -
Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
by: Linda K Mooberry, et al.
Published: (2016) -
The role of cholesterol metabolism and cholesterol transport in carcinogenesis; A review of scientific findings, relevant to future cancer therapeutics.
by: Pedro Miguel Cruz, et al.
Published: (2013) -
Pre-clinical evaluation of rHDL encapsulated retinoids for the treatment of Neuroblastoma
by: Nirupama eSabnis, et al.
Published: (2013)